Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Clin Microbiol Antimicrob ; 20(1): 14, 2021 Feb 27.
Article in English | MEDLINE | ID: mdl-33639961

ABSTRACT

BACKGROUND: HACEK (Haemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) group organisms are responsible for 0.8% to 6% of all infective endocarditis cases, with Cardiobacterium spp. being the third most commonly implicated HACEK microorganism. Within this genus is Cardiobacterium valvarum (C. valvarum), a novel organism described in 2004. To date, only 15 cases of C. valvarum infection have been reported in the English-language literature, and have primarily been cases of infective endocarditis in patients with valvular disease. C. valvarum has not been reported to cause infections spreading to the surrounding bone. CASE PRESENTATION: We present a case of a 57-year-old man with a history of aortic dissection followed by aortic endograft replacement who presented with back pain. He was found to have radiographic evidence of an infected aortic endograft, along with vertebral osteomyelitis, discitis, and epidural phlegmon. Blood cultures identified C. valvarum as the causative organism. The patient was treated with ceftriaxone and surgical intervention was deferred due to the patient's complex anatomy. His course was complicated by septic cerebral emboli resulting in cerebrovascular accident. CONCLUSIONS: This case report highlights C. valvarum, a rare and emerging HACEK group microorganism that warrants consideration in high-risk patients with evidence of subacute infection and disseminated disease. While C. valvarum classically presents as infective endocarditis, extra-cardiac manifestations have also been described. As demonstrated in this case, endograft involvement and osteomyelitis may occur in rare circumstances.


Subject(s)
Cardiobacterium , Endocarditis, Bacterial/microbiology , Osteomyelitis/microbiology , Anti-Bacterial Agents/therapeutic use , Aorta , Aorta, Thoracic/microbiology , Aorta, Thoracic/surgery , Endocarditis , Endocarditis, Bacterial/complications , Endocarditis, Bacterial/drug therapy , Humans , Male , Middle Aged , Osteomyelitis/complications , Osteomyelitis/diagnostic imaging , Osteomyelitis/drug therapy , Transplants
SELECTION OF CITATIONS
SEARCH DETAIL
...